1. Home
  2. NDLS vs ANEB Comparison

NDLS vs ANEB Comparison

Compare NDLS & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDLS
  • ANEB
  • Stock Information
  • Founded
  • NDLS 1995
  • ANEB 2020
  • Country
  • NDLS United States
  • ANEB United States
  • Employees
  • NDLS N/A
  • ANEB N/A
  • Industry
  • NDLS Restaurants
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NDLS Consumer Discretionary
  • ANEB Health Care
  • Exchange
  • NDLS Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • NDLS 29.8M
  • ANEB 111.8M
  • IPO Year
  • NDLS 2013
  • ANEB 2021
  • Fundamental
  • Price
  • NDLS $0.62
  • ANEB $2.56
  • Analyst Decision
  • NDLS Buy
  • ANEB Buy
  • Analyst Count
  • NDLS 2
  • ANEB 2
  • Target Price
  • NDLS $3.00
  • ANEB $8.00
  • AVG Volume (30 Days)
  • NDLS 124.1K
  • ANEB 29.2K
  • Earning Date
  • NDLS 11-05-2025
  • ANEB 11-12-2025
  • Dividend Yield
  • NDLS N/A
  • ANEB N/A
  • EPS Growth
  • NDLS N/A
  • ANEB N/A
  • EPS
  • NDLS N/A
  • ANEB N/A
  • Revenue
  • NDLS $494,752,000.00
  • ANEB N/A
  • Revenue This Year
  • NDLS $1.19
  • ANEB N/A
  • Revenue Next Year
  • NDLS N/A
  • ANEB N/A
  • P/E Ratio
  • NDLS N/A
  • ANEB N/A
  • Revenue Growth
  • NDLS N/A
  • ANEB N/A
  • 52 Week Low
  • NDLS $0.55
  • ANEB $0.80
  • 52 Week High
  • NDLS $1.74
  • ANEB $3.42
  • Technical
  • Relative Strength Index (RSI)
  • NDLS 41.44
  • ANEB 56.80
  • Support Level
  • NDLS $0.61
  • ANEB $2.30
  • Resistance Level
  • NDLS $0.69
  • ANEB $2.74
  • Average True Range (ATR)
  • NDLS 0.04
  • ANEB 0.14
  • MACD
  • NDLS 0.01
  • ANEB 0.03
  • Stochastic Oscillator
  • NDLS 16.09
  • ANEB 65.00

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: